You just read:

Allecra Therapeutics Announces Positive Top-Line Results from Phase 2 CACTUS Study of its Lead Candidate, AAI101, in Combination with Cefepime to Treat Complicated Urinary Tract Infections (cUTI)

News provided by

Allecra Therapeutics

Mar 26, 2018, 02:00 ET